Home › Funds › FULLER & THALER ASSET MANAGEMENT, INC. › EXEL

FULLER & THALER ASSET MANAGEMENT, INC. position in EXEL

EXELIXIS INC · Health Care

FULLER & THALER ASSET MANAGEMENT, INC. reported holding 8,795,928 shares of EXEL (EXELIXIS INC) in its Q3 2026 13F filing — a position valued at US$513.8M, representing 1.51% of its reported portfolio and ranking #2 among its reported holdings. FULLER & THALER ASSET MANAGEMENT, INC. has disclosed EXEL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)8.80M sh
Reported value held$513.77M
Portfolio Weight1.51%
First reportedQ3 2023
Last changeReduce
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How FULLER & THALER ASSET MANAGEMENT, INC.'s EXEL position evolved

FULLER & THALER ASSET MANAGEMENT, INC. first disclosed a stake in EXEL in Q3 2023 at 2,561,487 shares (US$56.0M). The position peaked in Q3 2026 at 8,795,928 shares, worth US$513.8M. Across 13 filings, FULLER & THALER ASSET MANAGEMENT, INC. increased the stake 8 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 8,795,928 shares valued at US$513.8M — a reduction of -133,461 shares quarter over quarter.. Notable position changes include a 212% increase in Q3 2024 (shares rose 28% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 2.56M $55.97M New
Q4 2023 2.62M $62.74M Add
Q1 2024 2.66M $63.08M Add
Q2 2024 2.22M $49.93M Reduce
Q3 2024 6.92M $179.64M Add
Q4 2024 7.63M $254.11M Add
Q1 2025 7.80M $287.79M Add
Q2 2025 8.78M $386.78M Add
Q3 2025 8.32M $343.65M Reduce
Q4 2025 7.96M $348.93M Reduce
Q1 2026 8.54M $366.38M Add
Q2 2026 8.93M $485.85M Add
Q3 2026 8.80M $513.77M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EXEL and 13F data

EXEL (EXELIXIS INC) is a Health Care company. 40 other funds we track also report a position in EXEL — the largest reported positions include Renaissance Technologies (US$747.2M), Farallon Capital Management (US$732.8M), FARALLON CAPITAL MANAGEMENT, L.L.C. (US$732.8M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EXEL

All EXEL fund holders →

FAQ

How long has FULLER & THALER ASSET MANAGEMENT, INC. held EXEL?

FULLER & THALER ASSET MANAGEMENT, INC. has disclosed EXEL holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is FULLER & THALER ASSET MANAGEMENT, INC.'s current position in EXEL?

As of Q3 2026, FULLER & THALER ASSET MANAGEMENT, INC. holds 8.80M shares of EXEL (EXELIXIS INC), valued at $513.77M, representing 1.51% of its reported portfolio and ranking #2.

Has FULLER & THALER ASSET MANAGEMENT, INC. been buying or selling EXEL?

In the latest 13F filing (Q3 2026), FULLER & THALER ASSET MANAGEMENT, INC. reduced its position in EXEL. The position peaked in Q3 2026 at 8.80M shares.

Which other funds hold EXEL?

Other major institutional holders of EXEL include Renaissance Technologies, Farallon Capital Management, FARALLON CAPITAL MANAGEMENT, L.L.C., among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.